A detailed history of Avion Wealth transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Avion Wealth holds 18 shares of NBIX stock, worth $2,117. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 26 30.77%
Holding current value
$2,117
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$114.58 - $153.15 $916 - $1,225
-8 Reduced 30.77%
18 $2,000
Q2 2024

Jul 26, 2024

BUY
$130.86 - $143.19 $523 - $572
4 Added 18.18%
26 $3,000
Q1 2024

May 03, 2024

BUY
$130.4 - $143.74 $1,564 - $1,724
12 Added 120.0%
22 $4,000
Q4 2023

Jan 26, 2024

SELL
$106.07 - $132.76 $1,060 - $1,327
-10 Reduced 50.0%
10 $1,000
Q3 2023

Oct 20, 2023

BUY
$94.02 - $117.1 $1,880 - $2,342
20 New
20 $2,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.